RSS   Newsletter   Contact   Advertise with us
Post Online Media

Celldex appoints chief product development officer

CelldexCelldex Therapeutics, Inc., a clinical-stage biotech company, promoted Elizabeth Crowley to the newly created position of SVP, chief product development officer.
Article continues below

READ MORE Celldex Therapeutics appointed Larry Ellberger as chairman

Ms. Crowley was previously Senior Vice President of Product Development of Celldex and brings almost 25 years of industry experience where she was responsible for leading the execution of multiple successful drug development programs.

Ms. Crowley joined Celldex in 2009 as Vice President, Clinical Development.

Prior to that, she held several senior level roles at CuraGen Corporation, most recently serving as the Vice President of Development Operations, responsible for strategic and operational development activities of the oncology and oncology supportive care portfolio, regulatory affairs, clinical operations and data management.

Ms. Crowley started her career at Bayer Corporation in 1992, holding various positions providing leadership of clinical research and project management prior to completing her tenure there as the Director of Global Study Audit Management, assuring the highest standards for program execution.

Ms. Crowley received her BS in Chemistry with a concentration in Business from Boston College.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy